-
-
-
-
-
-
-
Vertex (VRTX) PT Raised to $590 at Cantor Fitzgerald
-
-
-
-
-
-
-
Vertex Pharma (VRTX) Tops Q3 EPS by 23c, provides guidance
-
-
-
-
-
-
-
Vertex (VRTX) PT Lowered to $455 at Stifel
-
-
-
-
-
-
-
Scotiabank Reiterates Sector Perform Rating on Vertex (VRTX)
-
-
-
-
-
-
-
DA Davidson Reiterates Buy Rating on Vertex (VRTX)
-
-
-
-
-
-
-
Vertex Presents Positive Long-Term Data On CASGEVYâ„¢ (exagamglogene autotemcel) at the American Society of Hematology (ASH) Annual Meeting and Exposition and Provides Program Update
-
-
-
-
-
-
-
Vertex (VRTX) PT Raised to $576 at Wolfe Research
-
1,197,712 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

